Clinical Trial Update: A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants [Phase 2]

View source ↗

Summary

Phase 2 study evaluating BMS-986141 added to aspirin, ticagrelor, or both, on thrombus formation in a thrombosis chamber model in participants with stable coron…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• BMS-986141

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Coronary Artery Disease, Healthy Participants | Phase 2 | Status: COMPLETED | Results posted: 2023-12-05